NG
NervGen Pharma Corp. Common stock (NGEN)
NASDAQ·Healthcare·Biotechnology
$3.91
+1.43%
Mkt Cap $317.25M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.11 | -$0.26 | -125.77% | — | — |
NASDAQ·Healthcare·Biotechnology
$3.91
+1.43%
Mkt Cap $317.25M
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.11 | -$0.26 | -125.77% | — | — |